Endophthalmitis: A reappraisal of incidence and treatment

Current Opinion in Ophthalmology

Volumn 17, Issue 3, 2006, Pages 286-291

  Busbee, Brandon G ^a  

^a Retina Vitreous Associates   (United States)

Author keywords

Cataract; Endophthalmitis; Fourth generation fluoroquinolones; Intravitreal kenalog; Penetrating keratoplasty

Indexed keywords

ANTIBIOTIC AGENT; BACITRACIN; CEFAZOLIN; CIPROFLOXACIN; COTRIMOXAZOLE; POVIDONE IODINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

CATARACT; CATARACT EXTRACTION; ENDOPHTHALMITIS; HUMAN; INCIDENCE; LONGITUDINAL STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ANTI-BACTERIAL AGENTS; ENDOPHTHALMITIS; HUMANS; INCIDENCE; OPHTHALMOLOGIC SURGICAL PROCEDURES; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 33748136806     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.icu.0000193102.21174.a5     Document Type: Review

References (35)

1. Fine IH. Clear corneal incisions. Int Ophthalmol Clin 1994; 34:59-72.
2. Cooper BA, Holekamp NM, Bohigian G, Thompson PA. Case-control study of endophthalmitis after cataract surgery comparing scleral tunnel and clear corneal wounds. Am J Ophthalmol 2003; 136:300-305.
3. Nagaki Y, Hayasaka S, Kadoi C, et al. Bacterial endophthalmitis after small-incision cataract surgery; effect of incision placement and intraocular lens type. J Cataract Refract Surg 2003; 29:20-26.
4. Javitt JC, Vitale S, Canner JK, et al. National outcomes of cataract extraction: endophthalmitis following inpatient surgery. Arch Ophthalmol 1991; 109:1085-1089.
5. Khan RI, Kennedy S, Barry P. Incidence of presumed postoperative endophthalmitis in Dublin for a 5-year period (1997-2001). J Cataract Refract Surg 2005; 31:1575-1581.
6. Miller JJ, Scott IU, Flynn HW Jr. et al. Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol 2005; 139:983-987. A sound, retrospective review of the incidence of endophthalmitis in a single institution. Novel observations and comparisons to historical endophthalmitis rates are presented.
7. Monica ML, Long DA. Nine-year safety with self-sealing corneal tunnel incision in clear cornea cataract surgery. Ophthalmology 2005; 112:985-986. A favorable study in relation to clear corneal cataract surgery and complication rates.
8. Haapala TT, Nelimarkka L, Saari JM, et al. Endophthalmitis following cataract surgery in southwest Finland from 1987 to 2000. Graefes Arch Clin Exp Ophthalmol 2005; 243:1010-1017.
9. Lalitha P, Rajagopalan J, Prakash K, et al. Postcataract endophthalmitis in South India incidence and outcome. Ophthalmology 2005; 112:1884-1889.
10. Morel C, Gendron G, Tosetti D, et al. Postoperative endophthalmitis: 2000-2002 results in the XV-XX National Ophthalmologic Hospital. J Fr Ophtalmol 2005; 28:151-156.
11. Taban M, Behrens A, Newcomb RL, et al. Acute endophthalmitis following cataract surgery: a systematic review of the literature. Arch Ophthalmol 2005; 123:613-620. The first of a pair of articles from this author that reviews pertinent peer-reviewed literature on endophthalmitis over the past few decades.
12. Wejde G, Montan P, Lundstrom M, et al. Endophthalmitis following cataract surgery in Sweden: national prospective survey 1999-2001. Acta Ophthalmol Scand 2005; 83:7-10.
13. West ES, Behrens A, McDonnell PJ, et al. The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001. Ophthalmology 2005; 112:1388-1394. A Medicare sampling study that suggests a significant increase in incidence of postcataract endophthalmitis.
14. Kampougeris G, Antoniadou A, Kavouklis E, et al. Penetration of moxifloxacin into the human aqueous humour after oral administration. Br J Ophthalmol 2005; 89:628-631.
15. Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology 2002; 109:13-24.
16. Wejde G, Samolov B, Seregard S, et al. Risk factors for endophthalmitis following cataract surgery: a retrospective case-control study. J Hosp Infect 2005; 61:251-256. A case-control study attempting to identify risk factors for postcataract endophthalmitis.
17. Jensen MK, Fiscella RG, Crandall AS, et al. A retrospective study of endophtalmitis rates comparing quinolone antibiotics. Am J Ophthalmol 2005; 139:141-148. This study evaluates endophthalmitis cases over the course of several years and correlates the incidences to the type of perioperative topical antibiotic used.
18. McDonnell PJ, Taban M, Sarayba M, et al. Dynamic morphology of clear corneal cataract incisions. Ophthalmology 2003; 110:2342-2348.
19. Shingleton BJ, Wadhwani RA, O'Donoghue MW, et al. Evaluation of intraocular pressure in the immediate period after phacoemulsification. J Cataract Refract Surg 2001; 27:524-527.
20. Masket S. Is there a relationship between clear corneal cataract incisions and endophthalmitis? J Cataract Refract Surg 2005; 31:643-645.
21. Wallin T, Parker J, Jin Y, et al. Cohort study of 27 cases of endophthalmitis at a single institution. J Cataract Refract Surg 2005; 31:735-741.
22. Katz HR. A retrospective study of endophthalmitis rates comparing quinolone antibiotics. Am J Ophthalmol 2005; 140:771-772 (author reply 2-3).
23. Taban M, Behrens A, Newcomb RL, et al. Incidence of acute endophthalmitis following penetrating keratoplasty: a systematic review. Arch Ophthalmol 2005; 123:605-609. A systematic review of endophthalmitis rates associated with penetrating keratoplasty.
24. Westfall AC, Osborn A, Kuhl D, et al. Acute endophthalmitis incidence: intravitreal triamcinolone. Arch Ophthalmol 2005; 123:1075-1077.
25. Bucher RS, Hall E, Reed DM, et al. Effect of intravitreal triamcinolone acetonide on susceptibility to experimental bacterial endophthalmitis and subsequent response to treatment. Arch Ophthalmol 2005; 123:649-653. A well designed animal study outlining the effects of IVK in the setting of intraocular pathogenic bacteria in the rabbit eye model. This study may lead to further research regarding the use and risks of IVK in the eye.
26. Mitamura Y, Miyano N, Ohtsuka K. Bacterial endophthalmitis after triamcinolone acetonide-assisted pars plana vitrectomy. Jpn J Ophthalmol 2005; 49:538-539.
27. Smiddy WE, Smiddy RJ, Ba'Arath B, et al. Subconjunctival antibiotics in the treatment of endophthalmitis managed without vitrectomy. Retina 2005; 25:751-758. An excellent study that does not find a difference in outcome when using subconjunctival antibiotics in the setting of office-based intravitreal antibiotics for endophthalmitis.
28. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of post-operative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol 1995; 113:1479-1496.
29. Hariprasad SM, Mieler WF, Holz ER. Vitreous and aqueous penetration of orally administered gatifloxacin in humans. Arch Ophthalmol 2003; 121:345-350.
30. Busbee BG. Advances in knowledge and treatment: an update on endophthalmitis. Curr Opin Ophthalmol 2004; 15:232-237.
31. Katz HR, Masket S, Lane SS, et al. Absorption of topical moxifloxacin ophthalmic solution into human aqueous humor. Cornea 2005; 24:955-958.
32. Vedantham V, Lalitha P, Velpandian T, et al. Vitreous and aqueous penetration of orally administered moxifloxacin in humans. Eye 2005.
33. Kim DH, Stark WJ, O'Brien TP, Dick JD. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients. Ophthalmology 2005; 112:1992-1996. A comparative study evaluating the concentrations of fourth-generation fluoroquinolones in the anterior chamber.
34. Moshirfar M, Marx DP, Mirzaian G. Endophthalmitis in patients using fourth-generation fluoroquinolones following phacoemulsification. J Cataract Refract Surg 2005; 31:1669-1670.
35. Recchia FM, Busbee BG, Pearlman RB, et al. Changing trends in the microbiologic aspects of postcataract endophthalmitis. Arch Ophthalmol 2005; 123:341-346. A large, retrospective study that compares resistance patterns for endophthalmitis isolates over the time period 1989-2000.